<DOC>
	<DOC>NCT00767897</DOC>
	<brief_summary>The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.</brief_summary>
	<brief_title>The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>918yearold girls who have CKD stages 3 or 4 (Glomerular filtration rates 1559 mL/min/1.73m2). 918yearold girls who are on dialysis. 918yearold girls who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen. Healthy 918yearold girls Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood product received in the previous 6 months.</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Dose response relationship</keyword>
	<keyword>immunity</keyword>
</DOC>